Literature DB >> 24115904

Extractive spectrophotometric assay of cyclizine in a pharmaceutical formulation and biological fluids.

Nora Hamad Al-Shaalan1.   

Abstract

Two highly sensitive and simple spectrophotometric methods were developed to quantitate the drug cyclizine (CYC) in its pure form and in a pharmaceutical formulation. The two methods involved ion-associate formation reactions (method A) with mono-acid azo dyes, i.e., sudan (I) and sudan (II), as well as ion-pair reactions (method B) with bi-azo dyes, i.e., sudan (III), sudan (IV) and sudan red 7B (V). The reactions were extracted with chloroform, and the extraction products were quantitatively measured at 480, 550, 500, 530 and 570 nm using reagents I-V, respectively. The reaction conditions were monitored and optimised. The Beer plots for reagents I-V showed linear relationships for the concentrations of 4.2-52.0, 5.4-96.0, 3.5-43.0, 4.4-80.0 and 0.6-18.0 μg mL(-1), respectively, with molar absorptivities of 2.2 × 10(4), 4.1 × 10(4), 3.6 × 10(4), 2.5 × 10(4) and 1.3 × 10(4) L mol(-1) cm(-1), respectively. Sandell sensitivities and detection limits were calculated and analysed. The implementation of the two methods to the analysis of a commercial tablet (Valoid) succeeded, and the recovery study suggested that there was no interference from common excipients in the tablet. Regarding the accuracy and precision of the methods, a statistical comparison of the results was performed using Student's t-test and the F-test at the 95% confidence level. The accuracy and precision of the proposed methods were not significantly different.

Entities:  

Keywords:  Cyclizine; Spectrophotometry; Sudan dye; Valoid

Year:  2012        PMID: 24115904      PMCID: PMC3792629          DOI: 10.1016/j.jsps.2012.02.002

Source DB:  PubMed          Journal:  Saudi Pharm J        ISSN: 1319-0164            Impact factor:   4.330


  12 in total

1.  Kinetic spectrophotometric determination of some sulfur containing compounds in pharmaceutical preparations and human serum.

Authors:  M I Walash; M E-S Metwally; A M El-Brashy; A A Abdelal
Journal:  Farmaco       Date:  2003-12

2.  Effects of cyclizine hydrochloride and chlorcyclizine hydrochloride upon vestibular function.

Authors:  L B GUTNER; W J GOULD; A J CRACOVANER
Journal:  AMA Arch Otolaryngol       Date:  1954-04

3.  Spectrophotometric and LC determination of two binary mixtures containing antihistamins.

Authors:  Alaa El-Gindy; Samy Emara; Ahmed Mostafa
Journal:  Farmaco       Date:  2004-09

4.  A pharmacological study of N-methyl-N'-(4-chlorobenzhydryl) piperazine dihydrochloride, a new antihistaminic.

Authors:  J C CASTILLO; E J DE BEER; S H JAROS
Journal:  J Pharmacol Exp Ther       Date:  1949-08       Impact factor: 4.030

5.  The effectiveness of various drugs for the prophylaxis of seasickness.

Authors:  H I CHINN; S W HANDFORD; T E CONE; P K SMITH
Journal:  Am J Med       Date:  1952-04       Impact factor: 4.965

6.  Quantification of cyclizine and norcyclizine in human plasma by liquid chromatography-tandem mass spectrometry (LC-MS/MS).

Authors:  Berit Packert Jensen; Jane Winifred Ann Vella-Brincat; Evan James Begg
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2011-02-02       Impact factor: 3.205

7.  Assay of benzenoid drugs in tablet and capsule formulations by second-derivative ultraviolet spectrophotometry.

Authors:  A G Davidson; S M Hassan
Journal:  J Pharm Sci       Date:  1984-03       Impact factor: 3.534

8.  Assay of procyclidine hydrochloride, cyclizine hydrochloride and diethylcarbamazine citrate in tablets using ion-responsive electrodes.

Authors:  M J Campbell; B Demetriou; R Jones
Journal:  Analyst       Date:  1980-06       Impact factor: 4.616

9.  Analysis of some commercial preparations for migraine treatment using ion-pair high-performance liquid chromatography with addition of salts to the mobile phase.

Authors:  G K Low; P R Haddad; A M Duffield
Journal:  J Chromatogr       Date:  1983-06-03

10.  A capillary zone electrophoresis (CZE) method for the determination of cyclizine hydrochloride in tablets and suppositories.

Authors:  A Mohammadi; I Kanfer; R B Walker
Journal:  J Pharm Biomed Anal       Date:  2004-04-01       Impact factor: 3.935

View more
  1 in total

1.  Spectrofluorimetric Approach for Quantification of Cyclizine in the Presence of its Toxic Impurities in Human Plasma; in silico Study and ADMET Calculations.

Authors:  Michel Y Fares; Nada S Abdelwahab; Ghada M El-Sayed; Maha A Hegazy; Maha M Abdelrahman
Journal:  J Fluoresc       Date:  2022-03-03       Impact factor: 2.525

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.